<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35963198</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3964</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>EBioMedicine</Title><ISOAbbreviation>EBioMedicine</ISOAbbreviation></Journal><ArticleTitle>Anti-neuronal antibodies against brainstem antigens are associated with COVID-19.</ArticleTitle><Pagination><StartPage>104211</StartPage><MedlinePgn>104211</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">104211</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ebiom.2022.104211</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-3964(22)00393-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Understanding how SARS-CoV-2 affects respiratory centres in the brainstem may help to preclude assisted ventilation for patients in intensive care setting. Viral invasion appears unlikely, although autoimmunity has been implicated, the responsible antigens remain unknown. We previously predicted the involvement of three epitopes within distinct brainstem proteins: disabled homolog 1 (DAB1), apoptosis-inducing-factor-1 (AIFM1), and surfeit-locus-protein-1 (SURF1).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Here, we used microarrays to screen serum from COVID-19 patients admitted to intensive care and compared those with controls who experienced mild course of the disease.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">The results confirm the occurrence of IgG and IgM antibodies against the hypothesised epitopes in COVID-19 patients. Importantly, while IgM levels were similar in both groups, IgG levels were significantly elevated in severely ill patients compared to controls, suggesting a pathogenic role of IgG.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">The newly discovered anti-neuronal antibodies might be promising markers of severe disease and the targeted peptide epitopes might be used for targeted immunomodulation. Further work is needed to determine whether these antibodies may play a role in long-COVID.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">AF, CF and PR received support from the German Research Foundation (grants FL 379/22-1, 327654276-SFB 1315, FR 4479/1-1, PR 1274/8-1). SH, DR, and DB received support from the Ministry of Economy, State of Mecklenburg Western Pomerania, Germany (grant COVIDPROTECT: "Optimisation of diagnostic and therapeutic pathways for COVID-19 patients in MV"). SH received support from the Research Group Molecular Medicine University of Greifswald (FVMM, seed funding FOVB-2021-01). AV received support from the Else Kr&#xf6;ner Fresenius Foundation and the Alzheimer Research Initiative.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lucchese</LastName><ForeName>Guglielmo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medicine Greifswald, Ferdinand-Sauerbruch-Str. 1, Greifswald 17475, Germany. Electronic address: guglielmo.lucchese@uni-greifswald.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vogelgesang</LastName><ForeName>Antje</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medicine Greifswald, Ferdinand-Sauerbruch-Str. 1, Greifswald 17475, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boesl</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology and Experimental Neurology, Charit&#xe9; Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin, Berlin Institute of Health and Humboldt-Universit&#xe4;t zu Berlin, Charit&#xe9;platz 1, Berlin 10117, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raafat</LastName><ForeName>Dina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Immunology, University Medicine Greifswald, Ferdinand-Sauerbruch-Str. 1, Greifswald 17475, Germany; Department of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, Field of Khartoum 1, Alexandria 21521, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holtfreter</LastName><ForeName>Silva</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Immunology, University Medicine Greifswald, Ferdinand-Sauerbruch-Str. 1, Greifswald 17475, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Br&#xf6;ker</LastName><ForeName>Barbara M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Institute of Immunology, University Medicine Greifswald, Ferdinand-Sauerbruch-Str. 1, Greifswald 17475, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stufano</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Interdisciplinary Department of Medicine, University of Bari "Aldo Moro", Piazza Giulio Cesare 11, Bari 70124, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medicine Greifswald, Ferdinand-Sauerbruch-Str. 1, Greifswald 17475, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pr&#xfc;ss</LastName><ForeName>Harald</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology and Experimental Neurology, Charit&#xe9; Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin, Berlin Institute of Health and Humboldt-Universit&#xe4;t zu Berlin, Charit&#xe9;platz 1, Berlin 10117, Germany; German Center for Neurodegenerative Diseases (DZNE) Berlin, Charit&#xe9;platz 1, Berlin 10117, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franke</LastName><ForeName>Christiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology and Experimental Neurology, Charit&#xe9; Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin, Berlin Institute of Health and Humboldt-Universit&#xe4;t zu Berlin, Charit&#xe9;platz 1, Berlin 10117, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fl&#xf6;el</LastName><ForeName>Agnes</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medicine Greifswald, Ferdinand-Sauerbruch-Str. 1, Greifswald 17475, Germany; German Centre for Neurodegenerative Disease, Rostock-Greifswald, Ellernholzstra&#xdf;e 1-2, Greifswald 17489, Germany. Electronic address: agnes.floeel@med.uni-greifswald.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>EBioMedicine</MedlineTA><NlmUniqueID>101647039</NlmUniqueID><ISSNLinking>2352-3964</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001933" MajorTopicYN="N">Brain Stem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">Brainstem</Keyword><Keyword MajorTopicYN="N">Encephalitis</Keyword><Keyword MajorTopicYN="N">Epitopes</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of interests The Universit&#xe4;tsmedizin Greifswald has filed a patent application on immunomodulatory peptides for the treatment of SARS-CoV-2 infection, on which GL and AF are named as inventors. FB, AV, DR, SH, BB, AS, RF, HP declare that they have no competing interests. CF declares honoraria for lectures from Boehringer Ingelheim, Pfizer, and Bristol-Myers-Squibb.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>13</Day><Hour>18</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35963198</ArticleId><ArticleId IdType="pmc">PMC9365397</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2022.104211</ArticleId><ArticleId IdType="pii">S2352-3964(22)00393-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Herrmann J, Mori V, Bates JHT, Suki B. Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia. Nat Commun. 2020;11:4883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7522238</ArticleId><ArticleId IdType="pubmed">32985528</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a &#x201c;typical&#x201d; acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201:1299&#x2013;1300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233352</ArticleId><ArticleId IdType="pubmed">32228035</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain R, Lazarus MS, Roudenko A, et al. CT scans obtained for nonpulmonary indications: associated respiratory findings of COVID-19. Radiology. 2020;296:E173&#x2013;E179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437495</ArticleId><ArticleId IdType="pubmed">32391741</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Neurologic complications of coronavirus infections. Neurology. 2020;94:809&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">32229625</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang P, Tasch ES, Rapoport LN, Bakhadirov K. A post-infectious steroid-responsive brainstem lesion associated with COVID-19. Neurohospitalist. 2021;11:152&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7958677</ArticleId><ArticleId IdType="pubmed">33791060</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoo A, McLoughlin B, Cheema S, et al. Postinfectious brainstem encephalitis associated with SARS-CoV-2. J. Neurol. Neurosurg Psychiatry. 2020;91:1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">32636212</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeanneret V, Winkel D, Risman A, Shi H, Gombolay G. Post-infectious rhombencephalitis after coronavirus-19 infection: a case report and literature review. J Neuroimmunol. 2021;357</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8164357</ArticleId><ArticleId IdType="pubmed">34082192</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology. 2020;296:E119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233386</ArticleId><ArticleId IdType="pubmed">32228363</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267.</Citation><ArticleIdList><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucchese G. Cerebrospinal fluid findings in COVID-19 indicate autoimmunity. Lancet Microbe. 2020;1:e242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7541050</ArticleId><ArticleId IdType="pubmed">33047109</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimaldi S, Lagarde S, Harl&#xe9; JR, Boucraut J, Guedj E. Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from 18F-FDG PET imaging and neuronal autoantibodies. J Nucl Med. 2020;61:1726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8679632</ArticleId><ArticleId IdType="pubmed">32709734</ArticleId></ArticleIdList></Reference><Reference><Citation>Delamarre L, Gollion C, Grouteau G, et al. COVID-19&#x2013;associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network. J Neurol Neurosurg Psychiatry. 2020;91:1004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7476305</ArticleId><ArticleId IdType="pubmed">32651243</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A, Masciocchi S, Volonghi I, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses. Clin Infect Dis. 2021;73:e3019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799260</ArticleId><ArticleId IdType="pubmed">33395482</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C, Ferse C, Kreye J, et al. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun. 2021;93:415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucchese G, Fl&#xf6;el A. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons. Autoimmun Rev. 2020;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252083</ArticleId><ArticleId IdType="pubmed">32361194</ArticleId></ArticleIdList></Reference><Reference><Citation>Willers J, Lucchese A, Mittelman A, Dummer R, Kanduc D. Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis. Exp Dermatol. 2005;14:543&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pubmed">15946243</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastorino B, Touret F, Gilles M, Luciani L, de Lamballerie X. Charrel RN evaluation of chemical protocols for inactivating SARS-CoV-2 infectious samples. Viruses. 2020;12:624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7354533</ArticleId><ArticleId IdType="pubmed">32521706</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeloni S., Das S., Dunbar S., Stone V., Swift S. Vol. 4. Luminex Corporation; 2018. (xMAP&#xae; Cookbook. A Collection of Methods and Protocols for Developing Multiplex Assays with xMAP&#xae; Technology).</Citation></Reference><Reference><Citation>Meyer TC, Schmidt F, Steinke J, Br&#xf6;ker BM, V&#xf6;lker U, Michalik S. Technical report: xMAPr - High-dynamic-range (HDR) quantification of antigen-specific antibody binding. J Prot. 2020;212</Citation><ArticleIdList><ArticleId IdType="pubmed">31683064</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer TC, Michalik S, Holtfreter S, et al. A comprehensive view on the human antibody repertoire against staphylococcus aureus antigens in the general population. Front Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7987813</ArticleId><ArticleId IdType="pubmed">33777051</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz T, Heiss K, Mahendran Y, et al. M. SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients. Front Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8021850</ArticleId><ArticleId IdType="pubmed">33833755</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SE, Feng A, Meng W, et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun. 2021;12:5417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">17695343</ArticleId></ArticleIdList></Reference><Reference><Citation>Deguchi K, Inoue K, Avila WE, et al. Reelin and disabled-1 expression in developing and mature human cortical neurons. J Neuropathol Exp Neurol. 2003;62:676&#x2013;684.</Citation><ArticleIdList><ArticleId IdType="pubmed">12834112</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan W, Sherman D, Turesson J, Shao XM, Janczewski WA, Feldman JL. Reelin demarcates a subset of pre-B&#xf6;tzinger complex neurons in adult rat. J Comp Neurol. 2012;520:606&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3751584</ArticleId><ArticleId IdType="pubmed">21858819</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Hu Y, Zhou H, et al. Inhibition of progesterone receptor membrane component-1 exacerbates neonatal hypoxic-ischemic cerebral damage in male mice. Exp Neurol. 2022;347</Citation><ArticleIdList><ArticleId IdType="pubmed">34653511</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas N, Gurvich C, Kulkarni J. Sex differences and COVID-19. Adv Exp Med Biol. 2021;1327:79&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">34279830</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake NJ, Compton AG, Rahman S, Thorburn DR. Leigh syndrome: one disorder, more than 75 monogenic causes. Ann Neurol. 2016;79:190&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">26506407</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Wu W, Pan W, Wu L, Liu K, Zhang HL. Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder. Mediators Inflamm. 2015;2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4385702</ArticleId><ArticleId IdType="pubmed">25873770</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintana A, Zanella S, Koch H, et al. Fatal breathing dysfunction in a mouse model of Leigh syndrome. J Clin Invest. 2012;122:2359&#x2013;2368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3387817</ArticleId><ArticleId IdType="pubmed">22653057</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaelson NM, Malhotra A, Wang Z, et al. Peripheral neurological complications during COVID-19: a single center experience. J Neurol Sci. 2021;434</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8697415</ArticleId><ArticleId IdType="pubmed">34971857</ArticleId></ArticleIdList></Reference><Reference><Citation>Pareyson D, Piscosquito G, Moroni I, Salsano E, Zeviani M. Peripheral neuropathy in mitochondrial disorders. Lancet Neurol. 2013;12:1011&#x2013;1024.</Citation><ArticleIdList><ArticleId IdType="pubmed">24050734</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaishnav RA, Getchell ML, Huang L, Hersh MA, Stromberg AJ, Getchell TV. Cellular and molecular characterization of oxidative stress in olfactory epithelium of Harlequin mutant mouse. J Neurosci Res. 2008;86:165&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">17868149</ArticleId></ArticleIdList></Reference><Reference><Citation>Legros V, Denolly S, Vogrig M, et al. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity. Cell Mol Immunol. 2021;18:318&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7786875</ArticleId><ArticleId IdType="pubmed">33408342</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Hangen E, De Zio D, Bordi M, et al. A brain-specific isoform of mitochondrial apoptosis-inducing factor: AIF2. Cell Death Differ. 2010;17:1155.</Citation><ArticleIdList><ArticleId IdType="pubmed">20111043</ArticleId></ArticleIdList></Reference><Reference><Citation>Delettre C, Yuste VJ, Moubarak RS, Bras M, Robert N, Susin SA. Identification and characterization of AIFsh2, a mitochondrial apoptosis-inducing factor (AIF) isoform with NADH oxidase activity. J Biol Chem. 2006;281:18507.</Citation><ArticleIdList><ArticleId IdType="pubmed">16644725</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo PI. Role of natural autoantibodies and natural IgM anti-leucocyte autoantibodies in health and disease. Front Immunol. 2016;6:7&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4893492</ArticleId><ArticleId IdType="pubmed">27375614</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkon K, Casali P. Nature and functions of autoantibodies. Nat Clin Pract Rheumatol. 2008;4:491&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2703183</ArticleId><ArticleId IdType="pubmed">18756274</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J, James LC. Intracellular antibody immunity and its applications. PLoS Pathog. 2020;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7410306</ArticleId><ArticleId IdType="pubmed">32760166</ArticleId></ArticleIdList></Reference><Reference><Citation>Monta&#xf1;o J, Garnica J, Santamaria P. Immunomodulatory and immunoregulatory nanomedicines for autoimmunity. Semin Immunol. 56:101535.</Citation><ArticleIdList><ArticleId IdType="pubmed">34969600</ArticleId></ArticleIdList></Reference><Reference><Citation>Manry J, Bastard P, Gervais A, et al. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proc Natl Acad Sci USA. 2022;119</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9173764</ArticleId><ArticleId IdType="pubmed">35576468</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Benghanem S, Mazeraud A, Azabou E, et al. Brainstem dysfunction in critically ill patients. Crit Care. 2020;24:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6945639</ArticleId><ArticleId IdType="pubmed">31907011</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe1;bano-Su&#xe1;rez P, Bermejo-Guerrero L, M&#xe9;ndez-Guerrero A, et al. Generalized myoclonus in COVID-19. Neurology. 2020;95:e767&#x2013;e772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455360</ArticleId><ArticleId IdType="pubmed">32439821</ArticleId></ArticleIdList></Reference><Reference><Citation>Shetty K, Jadhav AM, Jayanthakumar R, et al. Myoclonus-ataxia syndrome associated with COVID-19. J Mov Disord. 2021;14:153&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8175811</ArticleId><ArticleId IdType="pubmed">33819422</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in Long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12:573.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Trotter J, Lee GH, Kazdoba TM, et al. DAB1 is required for synaptic plasticity and associative learning. J Neurosci. 2013;33:15652&#x2013;15668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3782631</ArticleId><ArticleId IdType="pubmed">24068831</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatemi SH, Earle JA, McMenomy T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry. 5:654&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">11126396</ArticleId></ArticleIdList></Reference><Reference><Citation>Inak G, Rybak-Wolf A, Lisowski P, et al. Defective metabolic programming impairs early neuronal morphogenesis in neural cultures and an organoid model of Leigh syndrome. Nat Commun. 2021;12:1929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997884</ArticleId><ArticleId IdType="pubmed">33771987</ArticleId></ArticleIdList></Reference><Reference><Citation>Khacho M, Clark A, Svoboda DS, et al. Mitochondrial dysfunction underlies cognitive defects as a result of neural stem cell depletion and impaired neurogenesis. Hum Mol Genet. 2017;26:3327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886206</ArticleId><ArticleId IdType="pubmed">28595361</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassianidis G, Siampanos A, Poulakou G, et al. Calprotectin and Imbalances between acute-phase mediators are associated with critical illness in COVID-19. Int J Mol Sci. 2022;23:4894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9099708</ArticleId><ArticleId IdType="pubmed">35563282</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC. Could SARS-CoV-2 spike protein be responsible for long-COVID syndrome? Mol Neurobiol. 2022;59:1850&#x2013;1861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbelo PD, Iadarola MJ, Keller JM, Warner BM. Autoantibodies targeting intracellular and extracellular proteins in autoimmunity. Front Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7982651</ArticleId><ArticleId IdType="pubmed">33763057</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher AJ, James LC. Coordinated neutralization and immune activation by the cytosolic antibody receptor TRIM21. J Virol. 2016;90:4856&#x2013;4859.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4859718</ArticleId><ArticleId IdType="pubmed">26937031</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui S, Alhamdi HWS, Alghamdi HA. Recent chronology of COVID-19 pandemic. Front Public Health. 2022;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9114873</ArticleId><ArticleId IdType="pubmed">35602161</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasello G, Armenia I, Molla G. The protein imager: a full-featured online molecular viewer interface with server-side HQ-rendering capabilities. Bioinformatics. 2020;36:2909&#x2013;2911.</Citation><ArticleIdList><ArticleId IdType="pubmed">31930403</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienert S, Waterhouse A, de Beer TA, et al. The SWISS-MODEL Repository-new features and functionality. Nucleic Acids Res. 2017;45:D313&#x2013;D319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5210589</ArticleId><ArticleId IdType="pubmed">27899672</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8371605</ArticleId><ArticleId IdType="pubmed">34265844</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>